Osage University Partners has launched efforts to raise a $250m third fund.
US-based spinout-focused investment firm Osage University Partners made a regulatory filing yesterday indicating it will seek $250m for its third fund.
The firm does not appear to have raised any money towards the fund yet.
Osage University Partners invests in spinouts and startups from 19 partner universities, such as Massachusetts Institute of Technology, Duke University and several University of California campuses.
The firm also has 68 associate partners both in the US, such as Cornell University, Johns Hopkins University and Fred Hutchinson Cancer Research Center, and internationally, such as National University of Singapore, Ben Gurion University of the Negev and Mars Innovation.
Osage previously filed for a $200m second fund in 2014 and closed a $100m vehicle in 2011. The firm has a portfolio of 79 companies across both existing funds.
Recent investments include Escient Pharmaceuticals, a biotech spinout from Johns Hopkins University, which raised a $40m series A round last month, and Embodied, a companion robot developer launched by a researcher from University of Southern California, which raised $22m in a series A round this week.
Osage University Partners was nominated for Investment Unit of the Year at the GUV Awards in 2017 and 2018.
Several members of the firm’s team are prolific writers and have contributed guest comments to the GUV magazine in the past, such as Kirsten Leute, senior vice-president of university relations, David Dorsey, associate, and Lou Berneman, founding partner.
Osage University Partners was not able to comment on the fundraising matter at this time.
